Event on

How can POCT benefit healthcare professionals in diagnosing and managing diabetes and comorbidities?

CONTEXTE

Join our panel of experts from around the world - USA, Japan and Switzerland - to learn how they use point of care testing for the management of their patients with diabetes and comorbidities.

This webinar will be chaired by Dr. Vivian Fonseca, an endocrinology, diabetes & metabolism specialist in Metairie, Louisiana, USA. He is current Chief, Endocrinology at the Tulane University School of Medicine.

Dr. Fonseca will start the webinar with his talk about the benefits HbA1c POC testing may provide.

Dr. Yasuhiro Iijima is diabetologist and director at the Fujiyasu Clinic and works also at the Department of Diabetes Metabolism and Endocrinology at Tokyo Medical University, Japan. Dr. Iijima will present his experience with POC lipid testing.

PD Dr. Andreas Kistler is Department Chief of Internal Medicine at the Kantonsspital Frauenfeld in Zurich, Switzerland. Dr. Kistler will share which impact the availability of ACR testing at the point-of-Care has on the identification and management of kidney disease.

Présentations

  • Dr. Vivian Fonseca

    Dr. Vivian Fonseca
    (USA)
    Chair

    The Value of point-of-care testing in Diabetes

  • PD Dr. Andreas David Kistler

    PD Dr. Andreas David Kistler
    (SWITZERLAND)
    Speaker

    Relevance of determining albuminuria in the practice

  • Dr. Yasuhiro Iijima

    Dr. Yasuhiro Iijima
    (JAPAN)
    Speaker

    Immediate lipid testing with POC is effective and attractive for the treatment and education of outpatients


Live stream will be held in English, Japanese, Spanish, Brazilian-Portuguese, German and Italian. Available on demand in two additional languages: French and Korean.


Les points de vues et opinions présentés n’engagent que les orateurs. Le contenu de ce webcast est destiné à des fins informatives / éducatives uniquement.

© 2023 Abbott. Tous les droits sont réservés. Toutes les marques commerciales référencées sont des marques commerciales du groupe de sociétés Abbott ou de leurs propriétaires respectifs. COL-00000

"-- SEO4AJAX --" "seo4ajax Access"

"-- SEO4AJAX --" "Init" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"fr","eventsSlug":"advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"}

"-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"fr","eventsSlug":"advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"} 200 "https://campus.meplis.com/mypocacademy/ww/fr/events/advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"

"-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"fr","eventsSlug":"advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"} 200 "https://campus.meplis.com/mypocacademy/ww/fr/events/advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"

"-- SEO4AJAX --" "Timeout: " 5 " seconds"

"-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mypocacademy/ww/fr/events/advantages-of-poct-for-screening-diagnosis-and-monitoring-of-diabetes-and-comorbidities"

"-- SEO4AJAX --" "Bugsnag Called"